Cargando…
P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
Autores principales: | Colombo, C., Alicandro, G., Daccó, V., Gagliano, V., Morlacchi, L.C., Casciaro, R., Pisi, G., Francalanci, M., Cavallo, A., Poli, P., Folino, A., Messore, B., Cristadoro, S., Leonetti, G., Maschio, M., Lucca, F., Cipolli, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192163/ http://dx.doi.org/10.1016/S1569-1993(21)01160-7 |
Ejemplares similares
-
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
por: Colombo, Carla, et al.
Publicado: (2021) -
ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022) -
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
por: Colombo, Carla, et al.
Publicado: (2021) -
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021) -
Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
por: Grancini, V., et al.
Publicado: (2023)